Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 4,180 shares at $58.92 ($246K) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Seasonal sale ($246k) by EVP, Chief Commercial Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.92 | 2,090 | $123K | 50.0% |
| 2 | $58.92 | 2,090 | $123K | 50.0% |
| Total | $58.92 avg | 4,180 | $246K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |
| MRTX | SELL | 2023-01-10 | $189K | — | Filing → |